US Neurosurgical Holding (US Neurosurgical Holding) COGS-to-Revenue : 0.00 (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is US Neurosurgical Holding COGS-to-Revenue?

US Neurosurgical Holding's Cost of Goods Sold for the three months ended in Mar. 2024 was $0.00 Mil. Its Revenue for the three months ended in Mar. 2024 was $0.00 Mil.

US Neurosurgical Holding's COGS to Revenue for the three months ended in Mar. 2024 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. US Neurosurgical Holding's Gross Margin % for the three months ended in Mar. 2024 was N/A%.

US Neurosurgical Holding COGS-to-Revenue Historical Data

The historical data trend for US Neurosurgical Holding's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

US Neurosurgical Holding COGS-to-Revenue Chart

US Neurosurgical Holding Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.11

0.08

US Neurosurgical Holding Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

US Neurosurgical Holding COGS-to-Revenue Calculation

US Neurosurgical Holding's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

US Neurosurgical Holding's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

US Neurosurgical Holding (OTCPK:USNU) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

US Neurosurgical Holding's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

US Neurosurgical Holding COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of US Neurosurgical Holding's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

US Neurosurgical Holding (US Neurosurgical Holding) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » US Neurosurgical Holding Inc (OTCPK:USNU) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

2400 Research Boulevard, Suite 325, Rockville, MD, USA, 20850

Website

http://www.usneuro.com

US Neurosurgical Holding Inc operates as a holding company in United State. It is a medical services company that partners with hospitals and physicians to operate facilities utilizing artistic and inventive technologies in medical treatment and diagnosis. It is engaged in providing medical treatment and diagnosis services that include stereotactic radiosurgery centers, utilizing gamma knife technology, and holds interests in radiological treatment facilities. The company is focusing on establishing cancer centers using intensity-modulated radiation therapy. Its gamma knife is a stereotactic radiosurgical device used to treat brain tumors and other malformations of the brain without invasive surgery.

Executives

Lawrence William St	director	23 ASHLAND STREET, NEWBURYPORT MA 01950-1905
William F. Leimkuhler	director	43 SALEM STRAITS RD, DARIEN CT 06820
Merriman Charles H Iii	director
Alan Gold	director, 10 percent owner, officer: President & Chairman	2400 RESEARCH BLVD, SUITE 325, ROCKVILLE MD 20850
Stanley S Shuman	10 percent owner	C/O RIPPLEWOOD HOLDINGS LLC, ONE ROCKERFELLER PLAZA, NEW YORK NY 10020
Allen & Co Inc	10 percent owner	711 FIFTH AVENUE, NEW YORK NY 10022

US Neurosurgical Holding (US Neurosurgical Holding) Headlines

No Headlines